🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

ICER's President and CEO Sarah Emond, MPP will be joining a panel at the UCSF Rosenman Symposium to discuss how to can make groundbreaking cancer therapies accessible while keeping our healthcare system sustainable on May 20th. Register here: lnkd.in/dxNsSrXF

On June 9th, ICER's President and CEO Sarah Emond, MPP will be part of a live recording for the "Prescription for Better Access" podcast on the future of US drug pricing and patient access at the ACCESS US'25 forum. Register now: theaccessforum.org

Want to work for a fast-paced, mission-driven organization? Look no further! ICER is looking to expand our team: grnh.se/0514dc8d3us

Miss ICER's webinar this week on #GLP-1 #obesity medications? Listen to the recording now: youtube.com/watch?feature=…

New from the "Insights from ICER" series in #HAScholar: Sarah K. Emond and Catherine Koola Fischer explore how ICER works to ensure that patient community voices and values are central in drug value assessments. Read the full article here: bit.ly/4jLLw2W

Health Affairs Scholar #HAScholar Health Affairs is delighted to publish the 1st article in its ongoing series with the Institute for Clinical and Economic Review ICER: “Insights from ICER: Drug Policy and Beyond”. ICER's work is widely disseminated & highly influential!

Institute for Clinical and Economic Review to Assess Treatments for Obesity Management: tinyurl.com/452a2w9t

ICER #WeeklyView: ICER @ ISPOR 2025, new obesity assessment, & 35 states opt-in to Medicaid sickle cell disease pilot conta.cc/4iEXPNx

Institute for Clinical and Economic Review Publishes Final Evidence Report on Treatment for Retinitis Pigmentosa: icer.org/pressreleases/…

ICER #WeeklyView: Trump admin’s MFN policy, Medicaid cuts, & RP Final Evidence Report conta.cc/42ZusRD

Institute for Clinical and Economic Review Publishes Protocol for First Annual Launch Price and Access Report: icer.org/pressreleases/…

Institute for Clinical and Economic Review to Assess Treatment for Smoking Cessation: icer.org/pressreleases/…

ICER #WeeklyView: A new ICER assessment, Launch Price and Access Report protocol, & states grapple with obesity Rx coverage conta.cc/4kaZjRo

Institute for Clinical and Economic Review Releases Draft Evidence Report on Treatments for Spinal Muscular Atrophy: tinyurl.com/yneckwdh

Institute for Clinical and Economic Review Publishes Evidence Report on Treatment for Secondary Progressive Multiple Sclerosis: tinyurl.com/mr3ywph8

ICER #WeeklyView: SMA Draft Report, MS Evidence Report, & Colorado PDAB on Enbrel conta.cc/4mAsaQy

ICER #WeeklyView: Reflections on obesity Rx, PBMs resist regulation of their retail pharmacies, & more US teens using weight loss Rx conta.cc/45tYcYH

This Friday -- at 12 PM ET join us for the virtual public meeting on the comparative clinical effectiveness and value of tolebrutinib (made by Sanofi) for the treatment of secondary progressive multiple sclerosis. Register here: shorturl.at/j33Ny #heor #hta

ICER #WeeklyView: Today’s MS public meeting, the uncertain future of ACIP, & Pfizer on MFN conta.cc/4jSpn2O

TODAY -- at 12 PM ET join us for the virtual public meeting on the comparative clinical effectiveness and value of tolebrutinib (made by Sanofi) for the treatment of secondary progressive multiple sclerosis. Register here: shorturl.at/j33Ny #heor #hta